Hims & Hers Health, INC Form 4 insider transactions

Hims & Hers Health CEO Andrew Dudum reports multiple transactions involving Class A Common Stock, including option exercises and sales, executed under a pre-arranged Rule 10b5-1 trading plan.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 4,152 shares of Class A Common Stock at a price of $60.69 on February 18, 2025.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., executed stock options and sold shares of Class A Common Stock according to a pre-arranged Rule 10b5-1 trading plan.

Melissa Baird, Chief Operating Officer of Hims & Hers Health, exercised stock options and sold shares of Class A Common Stock on February 12, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., executed stock options and sold shares of Class A Common Stock on February 10, 2025, according to a Form 4 filing with the SEC.

Hims & Hers Health CFO Oluyemi Okupe executed stock option exercises and sales of Class A Common Stock on February 10, 2025, according to a Form 4 filing.

Oluyemi Okupe, CFO of Hims & Hers Health, exercised stock options and sold shares of Class A Common Stock on February 4, 2025, under a pre-arranged Rule 10b5-1 trading plan.

CEO Andrew Dudum reports the vesting and disposal of Restricted Stock Units (RSUs) and the acquisition of Class A Common Stock due to the achievement of a performance threshold.

Andrew Dudum, CEO of Hims & Hers Health, exercised stock options and sold 100,000 shares of Class A Common Stock on January 31, 2025, according to a Form 4 filing with the SEC.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., reported the sale of 4,153 shares of Class A Common Stock on February 3, 2025, at a price of $35.3 per share.

Chief Commercial Officer Michael Chi of Hims & Hers Health, Inc. executed stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, executed a stock option exercise and subsequent sale of 17,304 Class A Common shares on January 24, 2025.

Hims & Hers CEO Andrew Dudum exercised stock options and sold shares on January 23, 2025, according to a recent SEC filing.

Boughton Soleil, Chief Legal Officer of Hims & Hers Health, exercised stock options and sold shares of Class A Common Stock on January 21, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Hims & Hers Health's Chief Operating Officer, Melissa Baird, exercised stock options and sold shares of Class A Common Stock on January 21, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., executed stock option exercises and sales under a pre-arranged Rule 10b5-1 trading plan.

Hims & Hers Health CEO Andrew Dudum exercised stock options and sold shares of Class A Common Stock under a pre-arranged Rule 10b5-1 trading plan.

CEO Andrew Dudum exercised stock options of Hims & Hers Health, Inc. under a pre-arranged 10b5-1 trading plan.

Hims & Hers CEO Andrew Dudum exercised stock options and sold a portion of his holdings in Class A Common Stock on January 16, 2025, under a pre-arranged 10b5-1 trading plan.

Chief Financial Officer Oluyemi Okupe of Hims & Hers Health, Inc. reports exercising stock options and selling Class A Common Stock under a pre-arranged Rule 10b5-1 trading plan.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, exercised stock options and sold shares of Class A Common Stock on January 10, 2025, according to a Form 4 filing.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., reports exercising stock options and selling Class A Common Stock under a pre-arranged Rule 10b5-1 trading plan.

Oluyemi Okupe, CFO of Hims & Hers Health, exercised stock options and sold shares of Class A Common Stock on January 2, 2025, according to a Form 4 filing with the SEC.

Chief Commercial Officer Michael Chi of Hims & Hers Health, Inc. reports exercising stock options and selling shares under a pre-arranged Rule 10b5-1 trading plan.

Melissa Baird, Chief Operating Officer of Hims & Hers Health, Inc., reports exercising stock options to acquire Class A Common Stock.

Hims & Hers Health, Inc. CFO, Oluyemi Okupe, sold 4,213 shares of Class A Common Stock at an average price of $29.9829 per share on December 26, 2024, under a pre-arranged 10b5-1 trading plan.

Chief Commercial Officer Michael Chi exercised stock options and sold shares of Hims & Hers Health, Inc. on December 24, 2024, according to a Form 4 filing.

Chief Commercial Officer Michael Chi exercised stock options and sold shares of Hims & Hers Health, Inc. under a pre-arranged Rule 10b5-1 trading plan.

Hims & Hers Health CFO Oluyemi Okupe sold shares of Class A Common Stock on December 20, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Hims & Hers CEO Andrew Dudum amended a previous SEC filing to accurately reflect his share transactions and holdings, including sales, acquisitions, and indirect ownership through various trusts.